A new study published in Annals of the American Thoracic Society highlighted subphenotypes of cystic fibrosis pulmonary exacerbations and differences in biomarker profiles, clinical presentation and outcomes.
“Using a predefined method of classification for cystic fibrosis pulmonary exacerbations, differences in clinical outcomes and inflammatory profiles were detected in three cohorts of cystic fibrosis patients with acute pulmonary exacerbations,” Suzanne C. Carter, MD, from the National Referral Centre for Adult Cystic Fibrosis at St. Vincent’s University Hospital in